PUBLIC CONTRACT · 2018
Aquisição de Tratamentos Hepatite C - Elbasvir 50 mg+Grazoprevir 100mg (CPA 2017/67)
- Contract value
- €67,007.39
- Signed on
- 9 May 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4534985PUBLISHED SUBJECT
Aquisição de Tratamentos Hepatite C - Elbasvir 50 mg+Grazoprevir 100mg (CPA 2017/67)
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Merck Sharp & Dohme, Lda. · Tax ID 500191360
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €67,007.39
- Procedure base price
- €67,007.40
- Total effective price
- Not reported on Portal BASE
- Publication date
- 7 June 2018
- Award date
- 9 May 2018
- Signing date
- 9 May 2018
- Performance period
- 240 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- CP 2017/67 - Medicamentos para a Hepatite C crónica
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3368772
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.